A Phase 1 Dose Escalation, Open-Label Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed Acute Lymphoblastic Leukemia
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Sep 2017
At a glance
- Drugs Navitoclax (Primary) ; Venetoclax (Primary) ; Dexamethasone; Pegaspargase; Vincristine
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AbbVie
- 31 Aug 2017 Planned End Date changed from 7 Mar 2020 to 12 Apr 2020.
- 31 Aug 2017 Planned initiation date changed from 25 Aug 2017 to 30 Sep 2017.
- 13 Jun 2017 New trial record